Script Care, Ltd.
Grant Gables has a strong background in the healthcare industry with a focus on managed care and national accounts. Their most recent position was as the Director of Managed Care and 340B Programs at Script Care, Ltd. Since joining in 2015, Grant has held a key leadership role in managing and overseeing these programs. Prior to that, they worked as a National Account Manager at Nipro Diagnostics from 2011 to 2015, where they were responsible for managing national accounts. Grant also has experience as a Senior Account Manager in Managed Care at Bayer HealthCare from 2006 to 2011. Grant began their career at Certified Diabetic Services in 2003 as the National Account Manager and Vice President of Managed Care. Overall, Grant's work experience demonstrates a strong understanding of the healthcare industry and a proven track record of success in managing accounts and implementing managed care strategies.
Grant Gables has a Bachelor of Business Administration (BBA) degree in Finance/Marketing from the Mays Business School at Texas A&M University. Additionally, they have earned a Master of Business Administration (MBA) degree in Finance from the C.T. Bauer College of Business at the University of Houston. No specific start or end years for these educational experiences were provided.
This person is not in any offices
Script Care, Ltd.
Script Care, Ltd. began operations as a PBM in 1986 and is the longest operating privately held PBM in the country. Today, SCL remains a family-owned company. The combination of this consistency in executive management and our maintained independence has ensured that SCL’s business philosophy remains focused solely on our clients’ needs. Our integrated management and centralized organizational structure allows SCL to react quickly and nimbly to changing market pressures; instead of working new policies and procedures through layers of management and protocol, ideas and improvements from virtually any employment levels can be immediately evaluated by Presidents and the CEO. This adaptability was recently capitalized upon during the early stages of the creation of the Affordable Care Act (ACA); by evaluating current operating procedures and their anticipated adherence to changing policies, SCL was able to react immediately to the ACA regulations and avoid any scrambling to “catch up” to industry expectations. In doing so, we removed the possibility of placing additional stress on our clients as they worked through their own ACA compliance processes. Finally, not only does our structure allow for flexibility and adaptability, but our independence demands it. SCL does not have the outside revenue streams that can help fund underperformance in other PBMs (ie. investors, mail order spread, drug manufacturer revenue, etc.) Instead, our success is based solely on the satisfaction of current and future customers, ensuring continuous thought innovation, market research and a genuine focus on client satisfaction. In short, SCL’s size and structure creates a company that is not only proud of our ability to offer outstanding service and products, but also one that appreciates the immediate relationship that your success has our own continued operations.